It is estimated that one million needlestick injuries occur in the European Union each year, with more than 100,000 occurring each year in the UK alone. In light of this, BD has launched a 5mm AutoShield Safety Pen Needle.
“Needlestick injuries are the most frequent occupational hazard faced by healthcare workers, including those caring for people with diabetes” says Carol Philipps, Business Director, UK and Ireland, BD Medical – Diabetes Care. “The BD AutoShield Safety Pen Needle is the latest in our portfolio of innovative products designed to help protect healthcare workers and patients from needlestick injury and possible infection.”
The BD AutoShield Safety Pen Needle incorporates a shield that automatically locks after injection to help prevent accidental needlestick injuries. Available in 29Gx5mm needle size in the UK, they are the only safety-engineered pen needles compatible with all brands of pens for diabetes treatment. Shorter needles are proven to be as effective as longer needles for patients of all body types, as well as offering a less intimidating and less painful injection experience, while reducing the risk of intramuscular injections.
